API
< Back to all clusters
[CRIME] · Brazil · 28 sources

started · updated

Anvisa seizes falsified cancer drug Phesgo and Dysport batches

Brazil's National Health Surveillance Agency (Anvisa) has ordered the seizure of falsified batches of the breast cancer drug Phesgo (lot B5011B05) and three batches of the botulinum toxin Dysport. Manufacturers Roche and Beaufour Ipsen confirmed the identified lots do not match original product characteristics.

Parallel to these sanitary measures, police are investigating a criminal network involving doctors, lawyers, and public servants suspected of defrauding cancer medication procurement. The scheme, which has impacted patients in at least four states—Rio Grande do Sul, Paraná, Mato Grosso do Sul, and Ceará—allegedly involved bid-rigging and the distribution of adulterated or unregistered high-cost drugs.

In Rio Grande do Sul, businessman Lisandro Henriques Hermes was arrested after police discovered boxes of medication showing signs of tampering. Investigations revealed that some patients were directed to specific lawyers to seek judicial authorization for medications, which were then supplied through fraudulent channels. The impact on patients has been severe, with reports of treatment interruptions and health deterioration.

Entities

Anvisa · Beaufour Ipsen Farmacêutica · Brasil · Brazil · Hospital de Câncer de Mato Grosso · Lisandro Henriques Hermes · Polícia Civil · Queen Pharma Aesthetic · Roche · Santa Casa de Caridade de São Gabriel · Secretaria de Estado de Saúde de Mato Grosso do Sul

Claims

What the coverage asserts, and how many sources carry each claim.

Sources